January 4, 2017 Life Science Tools M&A, Partnerships Microscopy

GrandOmics Biosciences Expands Investment in PacBio’s Sequel Systems for Precision Medicine Initiative

MENLO PARK, Calif. and BEIJING, Jan. 04, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that GrandOmics Biosciences Co., Ltd of Beijing, through its subsidiary NextOmics in Wuhan, has agreed to purchase five additional Sequel™ instruments to support China’s precision medicine initiative, with a specific focus on ultimately providing the genetic... Read more

December 15, 2016 Life Science Tools M&A, Partnerships

Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement

Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement Mountain View, CA and Ann Arbor, MI —December 15, 2016—Takara Bio USA Holdings, Inc. (“TBUSH”) and Rubicon Genomics, Inc. (“Rubicon”), today announced the signing of a merger agreement pursuant to which TBUSH will acquire Rubicon, a privately-owned company headquartered in Ann Arbor, Michigan. Rubicon... Read more

November 13, 2016 Bio/Pharma/CRO Life Science Tools Product Launch

QIAGEN Introduces Novel Technology for Customized RNAi Assay Products

VENLO, The Netherlands, November 13 /PRNewswire-FirstCall/ -- - Worldwide First Solution for Flexible siRNA Selection Provides New Dimension of Utility and Performance in one of Life Sciences' Most Promising Disciplines QIAGEN, (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) the world's leading provider of products for pre-analytical sample preparation and a leader in molecular diagnostics, has introduced... Read more

October 19, 2016 Life Science Tools Product Launch

SeqLL Launches Early Access Program for New true Single Molecule Sequencing (tSMS™) Benchtop System

Quantitative sequencing platform addresses limitations of other sequencing technologies October 19, 2016 06:42 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC today announced the launch of the tSMS System Early Access Program giving researchers priority access to its proprietary quantitative sequencing platform. This benchtop system has been designed to deliver unparalleled quantitative RNA and specialty... Read more

July 23, 2016 Bio/Pharma/CRO Life Science Tools M&A, Partnerships

QIAGEN Exchange Offer for Digene Corporation Expired With Significant Over 90% of Shares Tendered

VENLO, The Netherlands, July 23 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that its offer to exchange cash and stock for all outstanding shares of Digene Corporation (Nasdaq: DIGE) expired as scheduled at 11:59 p.m., New York City time, on Friday, July 20, 2007. All conditions of the exchange offer... Read more

November 9, 2015 Bio/Pharma/CRO Life Science Tools

It Takes Two: GE Healthcare and SHINE team up to solve longstanding radiopharmaceutical supply concerns in medical imaging

CHALFONT ST. GILES, UK – 9 November 2015 – Technetium-99m (Tc‑99m) is used in more than 40 million medical imaging procedures each year, primarily stress tests to assess heart disease, and bone scans to determine the stage of cancer progression. This essential medical isotope is generated in pharmacies and hospitals from another isotope—molybdenum-99 (Mo-99).  Despite... Read more

October 1, 2015 Life Science Tools

PacBio Sequencing for Human Biomedical Research to be Featured at ASHG Annual Meeting

MENLO PARK, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a pioneer and leader in long-read sequencing using Single Molecule, Real-Time (SMRT®) Technology, today announced that its technology will be featured in 36 presentations at next week’s American Society of Human Genetics (ASHG) 2015 annual meeting taking place in Baltimore,... Read more